White coat hypertension in pediatrics

被引:22
作者
Jurko, Alexander, Jr. [1 ]
Minarik, Milan [2 ]
Jurko, Tomas [3 ]
Tonhajzerova, Ingrid [4 ,5 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Pediat Cardiol Clin, Kollarova 2, Martin 03601, Slovakia
[2] Catholic Univ Ruzomberok, Fac Hlth Care, Ruzomberok, Slovakia
[3] Comenius Univ, Jessenius Fac Med Martin, Dept Neonatol, Martin, Slovakia
[4] Comenius Univ, Jessenius Fac Med Martin, Dept Physiol, Martin, Slovakia
[5] Comenius Univ, Jessenius Fac Med Martin, Martin Ctr Biomed BioMed, Martin, Slovakia
关键词
Hypertension; White coat; Blood pressure; Children; Cardiovascular; AMBULATORY BLOOD-PRESSURE; MASKED HYPERTENSION; CHILDREN; PATIENT;
D O I
10.1186/s13052-016-0213-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring.
引用
收藏
页数:5
相关论文
共 35 条
[1]  
Abir-Khalil S, 2009, East Mediterr Health J, V15, P400
[2]   Prevalence of overweight and obesity in European children below the age of 10 [J].
Ahrens, W. ;
Pigeot, I. ;
Pohlabeln, H. ;
De Henauw, S. ;
Lissner, L. ;
Molnar, D. ;
Moreno, L. A. ;
Tornaritis, M. ;
Veidebaum, T. ;
Siani, A. .
INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 :S99-S107
[3]  
[Anonymous], PEDIAT HYPERTENSION
[4]  
Badeli H, 2014, INT J PREVENTIVE MED, V5, pS17
[5]  
Bald M, 1999, PEDIATR NEPHROL, V13, P996
[6]  
Chrysant S.G., 2006, ADV THERAPY HYPERTEN, P537
[7]   Superiority of ambulatory over clinic blood pressure measurement in predicting mortality - The Dublin Outcome Study [J].
Dolan, E ;
Stanton, A ;
Thijs, L ;
Hinedi, K ;
Atkins, N ;
McClory, S ;
Den Hond, E ;
McCormack, P ;
Staessen, JA ;
O'Brien, E .
HYPERTENSION, 2005, 46 (01) :156-161
[8]  
Durdik P, 2003, ACTA MED, V3, P35
[9]  
Fisher M, 2005, J FAM PRACTICE, V54, P549
[10]   Ambulatory blood pressure in prehypertensive children and adolescents [J].
Fujita, Hisayo ;
Matsuoka, Seiji ;
Awazu, Midori .
PEDIATRIC NEPHROLOGY, 2012, 27 (08) :1361-1367